Diverse application coupled with increasing research and development funding worldwide in nanotechnology field is expected to drive market growth

Industry: Pharmaceuticals

Nanocapsules are a characteristic class of nanoparticles comprising core materials encapsulated by a protective matrix. The matrix encompasses the therapeutic substance and facilitates enhanced delivery of bio-active molecules. Nanocapsules have a broad range of life science applications and possess extremely high reproducibility properties. They may be applied in various fields such as healthcare, genetic engineering, food science and agriculture, cosmetics, agrochemicals, cleansing products, among others. These diverse applications have released unlimited opportunities for the research and future development of novel improved therapies. In addition, they can act as self-healing materials.

The application of nanotechnology to medicine can provide vital benefits in fields such as cancer, endocrinology, pain management, metabolic diseases, drug addiction, and others. Nanomedicine in the diagnosis and treatment of cancer, has the potential to transform clinical oncology by increasing the efficiency of cancer chemotherapy for a wide spectrum of invasive cancers. Several therapeutic nano-carriers have been approved for clinical use and others are undergoing phase II and III clinical trials.

In cosmetics, nanocapsule assists in targeting only specific areas with minimal systemic effects ensuring enhanced topical drug administration. L'Oreal has been the pioneer in adopting nanocapsule technology and its nanocapsules have been in the market since 1995. In agriculture, Nanotechnology introduces new delivery mechanisms to improve crop productivity, and it promises to reduce pesticide use, which is expected to boost nanocapsule to become the most important tools in modern agriculture practice.

Some of the major key players in the market include BioDelivery Sciences, Camurus, CARLINA Technologies, Cerulean Pharma Inc., NanoNutra, NanoSaar AG, ThioMatrix and L’Oreal. These companies are engaging actively in the development of novel products through partnerships between leading enterprises and nanomedicine startups. Nanocapsules is a niche market segment currently, and commercialization is yet to be reached to its maximum potential. Research and development and investment activities are being actively pursued, and the full scope of the market is yet to be realized.

  In-depth report on global nanocapsules market by Grand View Research:

http://www.grandviewresearch.com/industry-analysis/global-nanocapsules-market